Logo image of SPCE

VIRGIN GALACTIC HOLDINGS INC (SPCE) Stock Fundamental Analysis

NYSE:SPCE - New York Stock Exchange, Inc. - US92766K4031 - Common Stock - Currency: USD

2.97  -0.13 (-4.19%)

Premarket: 3.03 +0.06 (+2.02%)

Fundamental Rating

2

SPCE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 67 industry peers in the Aerospace & Defense industry. SPCE has a bad profitability rating. Also its financial health evaluation is rather negative. SPCE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year SPCE has reported negative net income.
SPCE had a negative operating cash flow in the past year.
SPCE had negative earnings in each of the past 5 years.
SPCE had a negative operating cash flow in each of the past 5 years.
SPCE Yearly Net Income VS EBIT VS OCF VS FCFSPCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

SPCE has a worse Return On Assets (-33.68%) than 76.12% of its industry peers.
SPCE has a Return On Equity of -114.94%. This is in the lower half of the industry: SPCE underperforms 79.10% of its industry peers.
Industry RankSector Rank
ROA -33.68%
ROE -114.94%
ROIC N/A
ROA(3y)-40.85%
ROA(5y)-47.15%
ROE(3y)-103.71%
ROE(5y)-94.59%
ROIC(3y)N/A
ROIC(5y)N/A
SPCE Yearly ROA, ROE, ROICSPCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SPCE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPCE Yearly Profit, Operating, Gross MarginsSPCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K -150K -200K -250K

3

2. Health

2.1 Basic Checks

SPCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SPCE has more shares outstanding
SPCE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, SPCE has a worse debt to assets ratio.
SPCE Yearly Shares OutstandingSPCE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SPCE Yearly Total Debt VS Total AssetsSPCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SPCE has an Altman-Z score of -4.65. This is a bad value and indicates that SPCE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SPCE (-4.65) is worse than 86.57% of its industry peers.
SPCE has a Debt/Equity ratio of 1.60. This is a high value indicating a heavy dependency on external financing.
SPCE has a Debt to Equity ratio of 1.60. This is amonst the worse of the industry: SPCE underperforms 82.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF N/A
Altman-Z -4.65
ROIC/WACCN/A
WACC5.16%
SPCE Yearly LT Debt VS Equity VS FCFSPCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.38 indicates that SPCE has no problem at all paying its short term obligations.
SPCE has a Current ratio of 3.38. This is in the better half of the industry: SPCE outperforms 70.15% of its industry peers.
A Quick Ratio of 3.38 indicates that SPCE has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.38, SPCE belongs to the top of the industry, outperforming 89.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.38
Quick Ratio 3.38
SPCE Yearly Current Assets VS Current LiabilitesSPCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.03% over the past year.
The Revenue for SPCE has decreased by -84.20% in the past year. This is quite bad
The Revenue has been growing by 13.23% on average over the past years. This is quite good.
EPS 1Y (TTM)51.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.74%
Revenue 1Y (TTM)-84.2%
Revenue growth 3Y28.84%
Revenue growth 5Y13.23%
Sales Q2Q%1.99%

3.2 Future

Based on estimates for the next years, SPCE will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.72% on average per year.
SPCE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 170.64% yearly.
EPS Next Y28.53%
EPS Next 2Y22.6%
EPS Next 3Y23.6%
EPS Next 5Y15.72%
Revenue Next Year-55.52%
Revenue Next 2Y328.1%
Revenue Next 3Y277.03%
Revenue Next 5Y170.64%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SPCE Yearly Revenue VS EstimatesSPCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
SPCE Yearly EPS VS EstimatesSPCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

1

4. Valuation

4.1 Price/Earnings Ratio

SPCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SPCE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPCE Price Earnings VS Forward Price EarningsSPCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPCE Per share dataSPCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as SPCE's earnings are expected to grow with 23.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.6%
EPS Next 3Y23.6%

0

5. Dividend

5.1 Amount

No dividends for SPCE!.
Industry RankSector Rank
Dividend Yield N/A

VIRGIN GALACTIC HOLDINGS INC

NYSE:SPCE (8/11/2025, 8:04:25 PM)

Premarket: 3.03 +0.06 (+2.02%)

2.97

-0.13 (-4.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners26.79%
Inst Owner Change-2.95%
Ins Owners0.88%
Ins Owner Change0.43%
Market Cap123.46M
Analysts53.85
Price Target4.55 (53.2%)
Short Float %29.08%
Short Ratio1.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.79%
Min EPS beat(2)13.07%
Max EPS beat(2)38.5%
EPS beat(4)4
Avg EPS beat(4)27.1%
Min EPS beat(4)13.07%
Max EPS beat(4)38.5%
EPS beat(8)8
Avg EPS beat(8)26.39%
EPS beat(12)9
Avg EPS beat(12)14.83%
EPS beat(16)10
Avg EPS beat(16)9.47%
Revenue beat(2)1
Avg Revenue beat(2)-6.29%
Min Revenue beat(2)-25.56%
Max Revenue beat(2)12.99%
Revenue beat(4)1
Avg Revenue beat(4)-43.94%
Min Revenue beat(4)-82.35%
Max Revenue beat(4)12.99%
Revenue beat(8)3
Avg Revenue beat(8)-25.82%
Revenue beat(12)5
Avg Revenue beat(12)27.42%
Revenue beat(16)8
Avg Revenue beat(16)48.62%
PT rev (1m)-52.02%
PT rev (3m)-49.46%
EPS NQ rev (1m)1.06%
EPS NQ rev (3m)10.46%
EPS NY rev (1m)0%
EPS NY rev (3m)3.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.26%
Revenue NY rev (1m)2.18%
Revenue NY rev (3m)86.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 72.71
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB 0.47
EV/EBITDA N/A
EPS(TTM)-9.04
EYN/A
EPS(NY)-6.39
Fwd EYN/A
FCF(TTM)-11.32
FCFYN/A
OCF(TTM)-7.02
OCFYN/A
SpS0.04
BVpS6.34
TBVpS6.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.68%
ROE -114.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-40.85%
ROA(5y)-47.15%
ROE(3y)-103.71%
ROE(5y)-94.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1057.47%
Cap/Sales 10528.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.38
Quick Ratio 3.38
Altman-Z -4.65
F-Score2
WACC5.16%
ROIC/WACCN/A
Cap/Depr(3y)422.61%
Cap/Depr(5y)296.8%
Cap/Sales(3y)1032.44%
Cap/Sales(5y)2081.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.74%
EPS Next Y28.53%
EPS Next 2Y22.6%
EPS Next 3Y23.6%
EPS Next 5Y15.72%
Revenue 1Y (TTM)-84.2%
Revenue growth 3Y28.84%
Revenue growth 5Y13.23%
Sales Q2Q%1.99%
Revenue Next Year-55.52%
Revenue Next 2Y328.1%
Revenue Next 3Y277.03%
Revenue Next 5Y170.64%
EBIT growth 1Y26.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.56%
EBIT Next 3Y28.65%
EBIT Next 5Y26.38%
FCF growth 1Y8.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.31%
OCF growth 3YN/A
OCF growth 5YN/A